Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NovoStent Appoints New Board Chairman NovoStent Corporation has appointed Rick Randall as board c - Medical Product Outsourcing

NovoStent Appoints New Board Chairman NovoStent Corporation has appointed Rick Randall as board c

NovoStent Appoints New Board Chairman


NovoStent Corporation has appointed Rick Randall as board chairman. Randall currently is chairman and CEO of Sunnyvale, Calif.-based Avantis Medical Systems Inc. and chairman of Wilmington, N.C.-headquartered TranS1 Inc. He also served as CEO of TranS1 from 2002 to 2011, resigning in January.


“We are delighted to have Rick join NovoStent as chairman,” said G. Ray Martin, Ph.D., president and CEO of NovoStent. “With his wealth of experience in the medical device industry, particularly with development stage companies, Rick is truly an asset to NovoStent.”


Randall’s medical device industry experience also includes a stint as president and CEO of Innovasive Devices Inc. until it was sold to Johnson & Johnson in 2000.


Mountain View, Calif.-based NovoStent manufactures products with an ultra-thin macro structure along with a micro cell structure that can be tailored for different vascular anatomies to enable easy deployment and accurate delivery of medication.


Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters